Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Levocarnitine Sf(Levocarnitine)ANI Pharmaceuticals, Inc. logoANIP

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by ANI Pharmaceuticals, Inc.

$79K

Medicare cost, 2024

Medicare drug plans spent $78,675 on Levocarnitine Sf (levocarnitine) in 2024, for 1,013 prescriptions and refills filled by 150 patients. Spending fell 25% from 2023 to 2024. Ohio accounts for the most spending ($8,016, 10% of the total). It is made by ANI Pharmaceuticals, Inc. (ANIP).

Medicare cost, 2024

$79K

-24.7% from 2023

Prescriptions

1,013

$77.67 per claim

Patients

150

169 prescribers

Total spending, 2024

$79K

$524.50 per patient

Questions and answers

How much does Medicare spend on Levocarnitine Sf?

Medicare prescription drug plans paid $79K for Levocarnitine Sf in 2024, for 1,013 prescriptions and refills to 150 patients (down 24.7% from 2023). The average cost per claim was $77.67.

Which state spends the most on Levocarnitine Sf?

Ohio had the highest Medicare cost for Levocarnitine Sf in 2024: $8,016 for 130 claims, followed by Michigan ($7,204).

Who prescribes Levocarnitine Sf the most?

Ayesha Ahmad, neurology in Washington, DC, had the highest Medicare cost for Levocarnitine Sf in 2024: 12 claims costing $3,723.

Who makes Levocarnitine Sf?

Levocarnitine Sf is made by ANI Pharmaceuticals, Inc. (ANIP), listed in the Medicare spending data as Novitium/Ani Ph.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Levocarnitine Sf was $79K in 2024, after a high of $104K in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Levocarnitine Sf, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Ayesha Ahmad Washington, DCNeurology12Under 11$3,723
Temenuzhka G Mihaylova Ann Arbor, MINeurology20Under 11$3,362
Rosalyn W Stewart Baltimore, MDPediatric Medicine12Under 11$2,377
Bernard T Sy Lebanon, TNInternal Medicine25Under 11$1,844
Steven S Kim Rolling Meadows, ILInternal Medicine53Under 11$1,771
Shaya Khabyeh-Hasbani Brooklyn, NYInternal Medicine44Under 11$1,725
Ritu Rastogi Wilmington, DEInternal Medicine52Under 11$1,681
Dawn T Zapinski Whiteland, INNeurology13Under 11$1,591
Francis Dimario Hartford, CTNeurology11Under 11$1,562
Jairon D Downs Raleigh, NCPhysical Medicine and Rehabilitation11Under 11$1,521
Melissa A Diggin Beverly, MANurse Practitioner11Under 11$1,392
Orlando Hernandez Cincinnati, OHInternal Medicine18Under 11$1,271
Wade Fornander Lincoln, NEFamily Practice14Under 11$1,107
Simon M Glynn Ann Arbor, MINeurology12Under 11$1,080
Bonnie Taft Stanford, CANurse Practitioner12Under 11$1,030
Jennifer N Brinton Salt Lake City, UTPediatric Medicine39Under 11$1,022
Carol N Larsen Sioux Falls, SDPhysician Assistant15Under 11$938
Elizabeth H Koontz Charleston, SCNurse Practitioner11Under 11$820
Terence A Frinks Tucker, GAFamily Practice20Under 11$773
Afshan Hameeduddin Schaumburg, ILFamily Practice21Under 11$757
Chloe E Hill Ann Arbor, MINeurology14Under 11$623
Katherine K Katsoyannis Park Ridge, ILInternal Medicine14Under 11$616
Daniel Miller Columbus, OHInternal Medicine14Under 11$539
Naveena Nelson Cincinnati, OHHospice and Palliative Care16Under 11$526
Olga Lansky Chicago, ILInternal Medicine18Under 11$522

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022149624126$88K
2023184895159$104K
20241691,013150$79K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Novitium/Ani PhANIP logoANIP1,013$79K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube